Herceptin (trastuzumab)
HERCEPTIN (trastuzumab) – an HER2/neu receptor antagonist commonly used to treat certain cancers. The HER2 (or c-erbB2) proto-oncogene encodes a transmembrane receptor protein of 185 kDa, which is structurally related to the epidermal growth factor receptor. Herceptin has been shown, in both in vitro assays and in animals, to inhibit the proliferation of human tumor […]